Definium Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $75.9M | $80.1M |
| FY2021 | — | $151.7M | $133.5M |
| FY2022 | — | $150.9M | $142.1M |
| FY2023 | $14.1M | $78.1M | $99.7M |
| FY2024 | $21.9M | $241.4M | $273.7M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $75.9M | $80.1M |
| FY2021 | — | $151.7M | $133.5M |
| FY2022 | — | $150.9M | $142.1M |
| FY2023 | $14.1M | $78.1M | $99.7M |
| FY2024 | $21.9M | $241.4M | $273.7M |